Interestingly, MYLK, MYH11, and FLNC were identified as pivotal genes in studies of the immune microenvironment [42], and MYLK and FLNC were found to be associated with prostate pathogenesis and prognosis [43]. The gene discussed is FLNC; the disease is urogenital neoplasm.